12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Cadrenal Therapeutics (NASDAQ:CVKD) shares moved upwards by 8.5% to $1.15 during Monday’s after-market session. The market value…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Aclarion (NASDAQ:ACON) stock rose 21.6% to $3.82 during Friday’s after-market session. The company’s market cap stands at…
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share.
Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal.
Ascent Industries shares surged 7.4% to $8.69 in pre-market trading.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers RayzeBio (NASDAQ:RYZB) stock rose 98.2% to $60.6 during Tuesday’s pre-market session. The company’s market cap stands at…
BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant and allowance of three patent applications for
BrainStorm Issues 2023 Letter To Shareholders; Says Our Focus Remains To Align With The FDA On A Phase 3b Trial Design, As We Acknowledge That This Represents The Most Expedient Pathway To Approval
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to shareholders.Dear Shareholders,We remain steadfast in our
Why BrainStorm Cell Therapeutics Shares Are Falling
Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) shares are trading lower by 22.6% to $0.23 Thursday afternoon after the company said it concluded a meeting with the FDA regarding NurOwn, its
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Yield10 Bioscience (NASDAQ:YTEN) shares rose 104.4% to $0.46 during Thursday’s regular session. The market value of their…
BrainStorm Cell Therapeutics Announces Outcome Of FDA Meeting On NurOwn In ALS
Meeting Provided a Clear Path for Planned Phase 3b TrialNEW YORK, Dec. 7, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for